Back to News
Market Impact: 0.25

PFE Quantitative Stock Analysis

PFENDAQ
Company FundamentalsCapital Returns (Dividends / Buybacks)Healthcare & BiotechAnalyst Insights
PFE Quantitative Stock Analysis

Validea's guru fundamental report indicates PFIZER INC (PFE) is its highest-rated stock under Meb Faber's Shareholder Yield Investor model, achieving a 70% score. This strategy targets companies that return cash to shareholders through dividends, buybacks, and debt paydown. While PFE passed key criteria such as net payout yield, valuation, and relative strength, it notably failed on quality/debt and shareholder yield; however, this 70% rating positions PFE as the top pick among Validea's 22 guru strategies for investors focused on shareholder returns.

Analysis

Pfizer Inc. (PFE) has been identified as the highest-rated security by Validea's Shareholder Yield Investor model, which is based on the strategy of Meb Faber. The stock achieved a score of 70%, a level that does not meet the 80% threshold typically indicating model interest, suggesting a qualified endorsement. The analysis presents a mixed fundamental picture: PFE passed the model's criteria for Net Payout Yield, Valuation, and Relative Strength, indicating favorable signals in its cash returns to shareholders, current market price, and recent performance momentum. However, it notably failed on two significant metrics: 'Quality and Debt' and, paradoxically, 'Shareholder Yield'. The failure on the debt criterion points to potential balance sheet risks, while failing the namesake 'Shareholder Yield' test, despite passing 'Net Payout Yield,' indicates a complex or contradictory signal regarding its capital return profile. The overall sentiment score of -0.1 reflects this conflicting assessment, where the top ranking under this specific screen is tempered by specific fundamental weaknesses.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mixed

Sentiment Score

-0.10

Ticker Sentiment

NDAQ0.00
PFE-0.10

Key Decisions for Investors

  • Investors should closely examine Pfizer's balance sheet and debt structure, as the failure on the 'Quality and Debt' metric presents a significant counterpoint to its positive valuation and payout signals.
  • Given the contradiction of failing the 'Shareholder Yield' test while being ranked highly by a model focused on that theme, it is prudent to analyze the specific components of PFE's capital return program, such as the mix of dividends, buybacks, and debt reduction.
  • The 70% score, while positioning PFE as a top pick in this specific screen, is not a strong conviction signal and suggests a cautious approach is warranted pending further due diligence on the identified fundamental weaknesses.